FCI Ophthalmics provides lacrimal stents and tubes for the comprehensive treatment of nasolacrimal duct obstruction in both infants and adults. FCI is a world leader in the research and development of devices used in lacrimal duct surgery. Along with the bicanalicular and monocalicular stents, FCI has also developed self-retaining stents to help physicians more easily perform lacrimal duct obstruction surgery.
If you would like to learn more about self-retaining stents, lacrimal tubes, and other products developed for the treatment of nasolacrimal duct obstruction, contact FCI Ophthalmics. One of our friendly and knowledgeable representatives can provide additional information or help you with your order.
The self-retaining bicanaliculus intubation set from FCI Ophthalmics allows physicians to effectively treat punctal stenosis and horizontal lacrimal duct obstruction.


Utilizing a non-traumatic metallic guide with an olive tip, Crawford Bicanaliculus Intubation is a highly effective tool for the treatment of canalicular system stenosis or nasolacrimal duct obstruction.



The Mono-Crawford is used for congenital nasolacrimal duct obstruction surgery and the treatment of canalicular lacerations. A single plug anchors Mono-Crawford lacrimal stents at the punctum.

This bicanaliculus method is designed for the treatment of canalicular stenosis or nasolacrimal duct obstruction.

The Infant Bika stent from FCI is used for infant canalicular stenosis and is recommended for DCR because of its high flexibility.

The Goldberg bicanaliculus cerclage is effectively used for reconstruction, trauma, and chronic stenosis of the canalicular system.

Transnasal lacrimal stents from FCI Ophthalmics address the limitations previously encountered with balloon catheter DCR and other forms of endoscopic DCR. The stent’s largest diameter rests in the ostium and lacrimal sac. Inserted through the nose, the lacrimal stent’s largest portion does not pass through the canaliculi.

Set Includes:
Lacrimal stent: 264 mm silicone multi-diameter stent with embedded short metal probe
Sheath/conduit: 170 mm polyetherimide tube used to introduce rod into lacrimal system and pull the transnasal lacrimal stent up through the nose and out of the canaliculus.
Metal rod: 175 mm stainless steel rod with blunt end
The Wide / Medium Collarette Monoka stent is securely anchored at the punctum by the plug. No knots or sutures are necessary. FCI Ophthalmics has designed the Wide and Medium Collarett Monoka stents to effectively treat congenital nasolacrimal duct obstruction and canalicular stenosis.

The Mini Monoka stent is securely anchored at the punctum by the plug. No knots or sutures are necessary. FCI Ophthalmics has designed Mini Monoka stents to effectively treat canalicular lacerations involving the external 2/3 of one canaliculus.


The disposable punctum dilator and plug inserter from FCI Ophthalmics is recommended for use when inserting the plug portion of the Mono-Crawford Monoka, Monoka, Mini-Monoka, and Self-Threading Monoka into the punctum.
Both the Ritleng Bicanaliculus Intubation and Self-Threading Monoka devices from FCI utilize PEEK (PolyEtherEtherKetone) as a thread guide to reduce time and trauma in lacrimal duct intubation surgery. The procedure involves inserting the hollow Ritleng Probe into the nasolacrimal duct and feeding a thin PEEK thread guide through it. The probe is then withdrawn, leaving the PEEK to pull the silicone tubing into place.

This highly effective self-threading monoka is designed for use in canalicular stenosis procedures and is securely anchored at the punctum by the plug. No knots or sutures are necessary.





In the Ritleng Probe procedure, the probe is backed out of the lacrimal ducts and separated from the PEEK thread guide at its thinner section (the lighter portion of the thread) by sliding it out from the open slit that lines the entire length of the probe.

Ritleng Probe Step 1

Ritleng Probe Step 2

Ritleng Probe Step 3

Ritleng Probe Step 4
View more detailed information regarding the Ritleng Probe Procedure
Contact us today if you would like to learn more about FCI Ophthalmic's devices for lacrimal duct surgery, including self-retaining stents and lacrimal stents and tubes. We will be happy to inform you of about the many benefits of our ophthalmic surgical devices.
FCI Ophthalmics
P.O. Box 465
Marshfield Hills, MA
02051
Tel: 866-595-4947
Tel: 781-826-9060
Fax: 781-826-90v62
To learn more about lacrimal stents for lacrimal duct surgery, lacrimal tubes, self-retaining stents, and other ophthalmic surgical devices, contact FCI Ophthalmics.